
...

By Jasmine Laws
Reporter
0
Share
Newsweek is a Trust Project member
See more of our trusted coverage when you search.Prefer Newsweek on Googleto see more of our trusted coverage when you search.
The U.S. Food and Drug Administration (FDA) has proposed withdrawing a rule that would have ensured certain cosmetics were tested for asbestos.
The rule was mandated under the 2022 Modernization of Cosmetics Regulation Act, requiring the FDA to implement methods of detecting and identifying the harmful carcinogenic chemical in talc-containing cosmetics.
A U.S. Department of Health and Human Services (HHS) spokesperson told Newsweek: "FDA remains committed to accessing the safety and necessity of the use of talc in the American food and drug supply."
Read More on News
They added that the agency will submit a "new proposed rule that offers a more comprehensive approach to reducing exposure to asbestos and reducing asbestos related illness, including identifying safer additives as alternatives, especially when they are less costly."
Why It Matters
Talc, also known as talcum powder, is widely used in cosmetics for its moisture-absorbing properties; however, the mineral can be contaminated with asbestos. Historically, a link was found between the use of talc and ovarian cancer, according to the University of Texas' MD Anderson Cancer Center.
The kind of products that may contain talc vary—such as mascaras, eye shadows, lip liners, foundation, tanning lotions and nail polish—according to the Environmental Working Group.
Asbestos was used by building and construction industries for strengthening cement and plastics as well as for insulation, roofing, fireproofing and sound absorption.
However, research has since uncovered significant health risks associated with the mineral, and it has been classified by various U.S. departments as a known human carcinogen.

...
What To Know
In its withdrawal notice, the FDA said it was scrapping the rule because of "comments received during the comment period for the proposed rule," which it said warranted "further consideration and assessment" before final regulations were established.
The agency received 49 comments in total in regard to the proposed rule, although it did not specify in its withdrawal note what the comments said, so it is unclear what concerns raised in the comments prompted the FDA's decision to further consider and assess the rule.
Had the 2024 rule been implemented, it would have required manufacturers of talc-containing cosmetic products to test their products and any talc ingredients used for asbestos and to keep records to demonstrate their compliance.
Any failure to comply with the rule, or the presence of asbestos in a given product or its talc ingredient, would have resulted in the FDA deeming a cosmetic product "adulterated under the Federal Food, Drug and Cosmetic Act."
If a product is considered adulterated, it means the FDA has determined it to bear or contain "any poisonous or deleterious substance which may render it injurious to users under the conditions of use prescribed."
The move comes after the U.S. Environmental Protection Agency said earlier this year it would reevaluate a policy, brought in by the agency under the Biden administration, that would have banned the use of asbestos in the U.S.—a policy that took a decades-long battle to be finalized.
What People Are Saying
Dr. Arthur Frank, a clinical professor of environmental and occupational health at Drexel University, told Newsweek: "It has become well documented that many talc-containing products do contain asbestos fibers. There is growing evidence that this asbestos causes traditional asbestos related cancers such as mesotheliomas. There is growing evidence that this can occur without any other documented exposure to asbestos. Contamination occurs naturally; asbestos and talc have similar chemical makeup and asbestos has been shown to be present in many talc deposits. It is not added to talc.
"I do have concern about this—without information proper scientific and preventive measures may not be taken to protect people. Nonhazardous products such as corn starch are available to replace asbestos-contaminated talc and should be used. A proper standardized technique allows all to properly measure asbestos in talc, replacing a current methodology that purposefully has been used that misses such contamination."
Dr. Philip Landrigan, director of the Program for Global Public Health and the Common Good, and professor of biology at Boston College, told Newsweek: "I consider it a serious mistake to withdraw this rule. Removing the requirement for manufacturers to test talc-containing products for asbestos will unnecessarily expose consumers, and especially women and their babies, to a powerful human carcinogen. Talc and asbestos are similar minerals that often can occur together in ore deposits. Thus, when talc is mined, asbestos is commonly present in the talc, and the two materials cannot easily be separated. The consequence is that many commercial talc formulations contain detectable levels of asbestos and have done so for many years. This is why it is so important to screen each batch of talc before it goes to market to be sure that it is free of asbestos.
"Asbestos is an extremely toxic material. Asbestos has been shown to cause multiple cancers, including lung cancer, laryngeal cancer, malignant mesothelioma [a cancer of the lining of the lungs] and ovarian cancer. The International Agency for Research on Cancer has concluded additionally that perineal [genital] use of talc-based body powder is 'probably carcinogenic to humans' and is specifically linked to ovarian cancer. Numerous lawsuits have been filed against Johnson & Johnson and other companies alleging that talcum powder caused ovarian cancer, leading to several multimillion-dollar verdicts and settlements."
What Happens Next
The administration's decision to scrap the rule is scheduled to be published in the Federal Register on November 28. After that, the withdrawal would be official.
Update 11/26/25, 10:51 a.m. ET: This article has been updated with comment from HHS.
Update 11/26/25, 11:30 a.m. ET: This article has been updated with comment from Dr. Philip Landrigan.
View 0 Comments
Submit Correction
View Editorial & AI Guidelines